Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Charite University, Berlin, Germany
Washirika
NSA, Collierville, TN, USA

Maneno muhimu

Kikemikali

The primary objective of this study is to determine the effect of an encapsulated juice powder concentrate on the number of days with at least moderate common cold symptoms over winter time.

Maelezo

Common cold is the most frequent acute illness in industrialised societies. Though it is usually benign, it is a leading cause of absence from work and doctor visits, causing an enormous economic burden including lost productivity and treatment costs.

Common cold is caused by a variety of viruses, with rhinoviruses and corona viruses as the most common. There is currently no treatment for common cold, thus therapy is focussed on symptom relief only. Prevention strategies for common cold include lifestyle measures such as avoiding infected people and regular hand washing during cold season. Dietary supplements including herbs and vitamins have been suggested as preventive strategies for common cold.

Juice Plus+® is a dietary supplement composed primarily of juice powder concentrate and pulp from fruits and vegetables. It contains several antioxidants including vitamin C, vitamin E, beta-carotene and folate. One randomized study reported reduction in work days lost to illness in the Juice Plus+® group compared to the placebo group. However, the clinical benefit for preventing common cold symptoms has not yet been tested in a large adult population.

Tarehe

Imethibitishwa Mwisho: 08/31/2010
Iliyowasilishwa Kwanza: 10/20/2008
Uandikishaji uliokadiriwa Uliwasilishwa: 10/20/2008
Iliyotumwa Kwanza: 10/22/2008
Sasisho la Mwisho Liliwasilishwa: 09/08/2010
Sasisho la Mwisho Lilichapishwa: 10/04/2010
Tarehe ya matokeo ya kwanza yaliyowasilishwa: 09/08/2010
Tarehe ya matokeo ya kwanza ya QC yaliyowasilishwa: 09/08/2010
Tarehe ya matokeo ya kwanza kuchapishwa: 10/04/2010
Tarehe halisi ya kuanza kwa masomo: 08/31/2008
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 06/30/2009
Tarehe ya Kukamilisha Utafiti: 06/30/2009

Hali au ugonjwa

Common Cold

Uingiliaji / matibabu

Dietary Supplement: Juice Plus

Dietary Supplement: Placebo

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: Juice Plus
Dietary Supplement: Juice Plus
Juice Plus+® is a dietary supplement from concentrated fruits (apple, orange, pineapple,cranberry, cherry (acerola), papaya and peach) and vegetables (carrot, parsley, beet, broccoli, kale, cabbage, spinach, and tomato). Subjects will take four capsules of Juice Plus+® daily.
Placebo Comparator: Placebo
Dietary Supplement: Placebo
Four capsules of placebo daily.

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Female or male, 18-65 years of age.

- Able and willing to take the active or placebo capsules over the whole study period.

- Health care professionals with essential patient contact (physicians, nurses, physiotherapists, etc) in Berlin, Germany.

- Written informed consent.

Exclusion Criteria:

- Known or suspected hypersensitivity or allergy to one of the ingredients of Juice Plus+®.

- Refusal to stop intake of additional vitamin supplements during study.

- Pregnancy or Lactation.

- Alcohol addiction, drug abuse or any other condition considered by the investigator to interfere with study procedures.

- Language limitations regarding interviews and questionnaires.

Matokeo

Hatua za Matokeo ya Msingi

1. Number of Days With at Least Moderate (i.e. Moderate or Severe) Common Cold Symptoms. [within 6 months (after 2 months run-in period)]

Hatua za Matokeo ya Sekondari

1. Secondary Endpoints of This Study Are Mean Health-related Quality of Life, Mean Common Cold Related Total Costs, Direct and Indirect (Productivity Loss) Costs [Baseline, months 2,4,6,8.]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge